Pharmacy Board of Australia v Beissel

Link copied
Case Copied 16 min read
CITATION: Pharmacy Board of Australia v Beissel [2012] QCAT 688
PARTIES: Pharmacy Board of Australia
(Applicant)
v
Graham Beissel
(Respondent)
APPLICATION NUMBER: OCR256-11
MATTER TYPE: Occupational regulation matters
HEARING DATE: On the papers
HEARD AT: Brisbane
DECISION OF: Kerrie O’Callaghan, A/Deputy President
DELIVERED ON: 13 December 2012
DELIVERED AT: Brisbane
ORDERS MADE:

1.   Mr Beissel must provide the Board with his signed and dated undertakings in the terms detailed in Annexure A within 14 days.

2.   Upon the copy of the undertakings being filed in the Tribunal, the following orders will be made.

(a)   Mr Beissel is reprimanded.

(b) Mr Beissel must not apply to the Chief Executive, Queensland Health, for reinstatement of his unrestricted endorsement for pseudoephedrine under sections 171 and 257 of the Health (Drugs and Poisons) Regulation 1996, for a period of twelve (12) months from the date of this order.

(c)   Mr Beissel must pay the Board’s reasonable and necessary costs of and incidental to the proceedings in the sum as agreed or assessed on the standard basis pursuant to the District Court of Queensland’s Scale of Fees (excluding any costs of the amended referrals and the expert report of Ms Woodhouse).

3.    If Mr Beissel does not comply with order 1, the matter will be listed before the Tribunal for further hearing on sanction.

CATCHWORDS:

PROFESSIONS AND TRADES – HEALTH CARE PROFESSIONALS – PHRMACUETICAL CHEMISTS – DISCIPLINARY PROCEEDINGS – MISCONDUCT IN A PROFESSIONAL RESPECT – where the Registrant failed to keep records of pseudoephedrine sales – whether the Registrant’s conduct amounted to professional misconduct or unprofessional conduct – costs – where consideration of what costs were “reasonable and necessary”

Health (Drugs and Poisons) Regulation 1996, r 285A
Health Practitioner National Law Act 2009, Schedule, ss 5, 195, 289
Health Practitioners (Professional Standards) Act 1999, s 124, Schedule
Queensland Civil and Administrative Tribunal Act 2009, s 32

Adamson v Queensland Law Society Incorporated (1991) QR 498
Allinson v General Council of Medical Education Registration [1894] 1 QB 750
Health Care Complaints Commission v Tiong [2012] NSWMT 6
Legal Services Commissioner v Madden [2008] QCA 301
Medical Board of Queensland v Alroe [2005] QHPT 004
Medical Board of Queensland v Cooke [1992] 2 Qd R 608
Medical Radiation Technologists Board of Queensland v Hennig [2010] QCAT 609
Nursing and Midwifery Board of Australia v Brocklehurst [2011] QCAT 071
Nursing and Midwifery Board of Australia v Carroll [2011] QCAT 262
Nursing and Midwifery Board of Australia v Farley [2011] QCAT 162
Nursing and Midwifery Board of Australia v Heather [2010] QCAT 423
Pharmacy Board of Australia v Chung [2012] QCAT 483
Pharmacy Board of Australia v Kent [2012] QCAT 329
Pharmacy Board of Australia v Kinsey [2012] QCAT 359
Pharmacy Board of Australia v The Registrant [2012] QCAT 359
Pillai v Messiter (No 2) (1989) 16 NSWLR 197

APPEARANCES and REPRESENTATION (if any):

This matter was heard and determined on the papers pursuant to s 32 of the Queensland Civil and Administrative Tribunal…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Pharmacy Board of Australia v Beissel and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2012] QCAT 688
Decision Date

CaseChat Overview and Summary

In the matter of Pharmacy Board of Australia v Beissel, the respondent, Mr Beissel, faced disciplinary proceedings for failing to maintain records of pseudoephedrine sales, which was considered a professional lapse. The Pharmacy Board of Australia pursued the case, alleging that Mr Beissel's actions amounted to professional misconduct or at least unprofessional conduct. The tribunal was tasked with determining the nature and severity of the misconduct and deciding on appropriate sanctions, including potential costs.

The primary legal issue revolved around whether Mr Beissel's failure to keep records of pseudoephedrine sales constituted professional misconduct or unprofessional conduct under the Health (Drugs and Poisons) Regulation 1996. The tribunal had to assess the gravity of the breach and whether it warranted a reprimand or more severe penalties. Additionally, the court needed to determine what costs, if any, Mr Beissel should be required to pay, considering the "reasonable and necessary" criteria.

The tribunal found that Mr Beissel's conduct amounted to unprofessional conduct but not to professional misconduct. Consequently, the tribunal decided on a reprimand and prohibited Mr Beissel from applying for reinstatement of his unrestricted endorsement for pseudoephedrine for twelve months. The tribunal also ordered Mr Beissel to pay the Board's reasonable and necessary costs of the proceedings, excluding certain specified costs. Failure to comply with the initial order to provide undertakings would result in further hearings on additional sanctions.

In summary, Mr Beissel was reprimanded and barred from applying for reinstatement of his endorsement for a year. He was also required to pay the Board's reasonable and necessary costs, excluding those of the amended referrals and an expert report. Non-compliance with the initial order would lead to further hearings regarding potential additional sanctions.

Orders

Orders of the court

1. Mr Beissel must provide the Board with his signed and dated undertakings in the terms detailed in Annexure A within 14 days.

2. Upon the copy of the undertakings being filed in the Tribunal, the following orders will be made.

(a) Mr Beissel is reprimanded.

(b) Mr Beissel must not apply to the Chief Executive, Queensland Health, for reinstatement of his unrestricted endorsement for pseudoephedrine under sections 171 and 257 of the Health (Drugs and Poisons) Regulation 1996, for a period of twelve (12) months from the date of this order.

(c) Mr Beissel must pay the Board’s reasonable and necessary costs of and incidental to the proceedings in the sum as agreed or assessed on the standard basis pursuant to the District Court of Queensland’s Scale of Fees (excluding any costs of the amended referrals and the expert report of Ms Woodhouse).

3. If Mr Beissel does not comply with order 1, the matter will be listed before the Tribunal for further hearing on sanction.